- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹200 | - |
Expense Ratio | 2.45 | - |
NAV | ₹28.55 | - |
Fund Started | 08 Feb 2019 | - |
Fund Size | ₹86.26 Cr | - |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.45
-
NAV
₹28.55
-
Fund Started
08 Feb 2019
-
Fund Size
₹86.26 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
Returns
1 Year | 26.53% | - |
3 Year | 17.36% | - |
5 Year | 21.18% | - |
1 Year
26.53%
-
3 Year
17.36%
-
5 Year
21.18%
-
Holding Analysis
Equity | 97.00% | - |
Cash | 3.00% | - |
Equity
97.00%
-
Cash
3.00%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.46% |
Piramal Pharma Ltd. | 7.02% |
Artemis Medicare Services Ltd. | 6.22% |
Torrent Pharmaceuticals Ltd. | 5.28% |
Glenmark Pharmaceuticals Ltd. | 4.59% |
Mankind Pharma Ltd. | 4.51% |
Cipla Ltd. | 4.33% |
Ipca Laboratories Ltd. | 4.21% |
JB Chemicals & Pharmaceuticals Ltd. | 4.14% |
Abbott India Ltd. | 4.12% |
-
Fund Manager
Name | Karan Doshi | - |
Start Date | 31 Jul 2023 | - |
Name
Karan Doshi
-
Start Date
31 Jul 2023
-
About Fund
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | - |
Launch Date | 08 Feb 2019 | - |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-
